Stress-related mucosal disease in the intensive care unit: An update on prophylaxis

AACN Advanced Critical Care

Volumn 18, Issue 2, 2007, Pages 119-128

  Sesler, Jefferson M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Gastrointestinal bleeding; Intensive care unit; Stress ulcer prophylaxis; Stress related mucosal bleeding; Stress related mucosal disease

Indexed keywords

ANTACID AGENT; ANTIULCER AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP; SUCRALFATE;

CRITICAL ILLNESS; DRUG ANTAGONISM; ENTERIC FEEDING; HUMAN; INCIDENCE; INTENSIVE CARE; INTENSIVE CARE UNIT; MENTAL STRESS; METHODOLOGY; NURSING ASSESSMENT; PATIENT SELECTION; PRIMARY PREVENTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; STOMACH MUCOSA; STOMACH ULCER; STRESS;

ANTACIDS; ANTI-ULCER AGENTS; CRITICAL CARE; CRITICAL ILLNESS; ENTERAL NUTRITION; GASTRIC MUCOSA; HISTAMINE H2 ANTAGONISTS; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; NURSING ASSESSMENT; PATIENT SELECTION; PRIMARY PREVENTION; PROTON PUMPS; RISK ASSESSMENT; RISK FACTORS; STOMACH ULCER; STRESS; STRESS, PSYCHOLOGICAL; SUCRALFATE;

EID: 34250648482     PISSN: 15597768     EISSN: 15597768     Source Type: Journal    
DOI: 10.4037/15597768-2007-2004     Document Type: Review

References (50)

1. American Society of Health-System Pharmacists. Therapeutic guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm. 1999;56(4):347-379.
2. Schuster DP. Stress ulcer prophylaxis: in whom? With what? Crit Care Med. 1993;21:4-6.
3. Schuster DP, Rowley H, Feinstein S, et al. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med. 1984;76:623-630.
4. Duerksen DR. Stress-related mucosal disease in critically ill patients. Best Pract Res Clin Gastroenterol. 2003;17:327-344.
5. Spirt MJ. Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther. 2004;26:197-213.
6. Tryba M, Cook D. Current guidelines on stress ulcer prophylaxis. Drugs. 1997;54:581-596.
7. Cook DJ, Fuller HD, Guyatt GH, et al, for the Canadian Critical Care Trials Group. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med. 1994;330:377-381.
8. Cook DJ, Griffith LE, Walter SD, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care. 2001;5:368-375.
9. Spirt MJ, Stanley S. Update on stress ulcer prophylaxis in critically ill patients. Crit Care Nurse. 2006;26(1):18-29.
10. Metz DC. Preventing the gastrointestinal consequences of stress-related mucosal disease. Curr Med Res Opin. 2005;21:11-18.
11. Martindale RG. Contemporary strategies for the prevention of stress-related mucosal bleeding. Am J Health Syst Pharm. 2005;62(10, suppl 2):S11-S17.
12. Lewis JD, Shin EJ, Metz DC. Characterization of gastrointestinal bleeding in severely ill hospitalized patients. Crit Care Med. 2000;28:46-50.
13. Mutlu GM, Mutlu EA, Factor P. GI complications in patients receiving mechanical ventilation. Chest. 2001;119:1222-1241.
14. Fennerty MB. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Crit Care Med. 2002;30(6, suppl):S351-S355.
15. Harty RF, Ancha HB. Stress ulcer bleeding. Curr Treat Options Gastroenterol. 2006;9(2):157-166.
16. Ben-Menachem T, Fogel R, Patel RV, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. Ann Int Med. 1994;121:568-575.
17. Pimental M, Roberts DE, Bernstein CN, et al. Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis. Am J Gastroenterol. 2000;95:2801-2806.
18. Cook D, Heyland D, Griffith L, et al, for the Canadian Critical Care Trial Group. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Crit Care Med. 1999;27:2812-2817.
19. Kantorova I, Svoboda P, Scheer P, et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepato- Gastroenterology. 2004;51:757-761.
20. Faisy C, Guerot E, Diehl J, et al. Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxis. Int Care Med. 2003;29:1306-1313.
21. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998;338:791-797.
22. Messori A, Trippoli S, Vaiani M, et al. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomized controlled trials. BMJ. 2000;321:1103-1106.
23. MacLaren R, Jarvis CL, Fish DN. Use of enteral nutrition for stress ulcer prophylaxis. Ann Pharmacother. 2001;35:1614-1623.
24. Daley RJ, Rebuck JA, Welage LS, et al. Prevention of stress ulceration: current trends in critical care. Crit Care Med. 2004;32:2008-2013.
25. Smythe MA, Zarowitz BJ. Changing perspectives of stress prophylaxis. Ann Pharmacother. 1994;28:1073-1085.
26. Omeprazole. Drugs facts and comparisons. Efacts [online]. 2006 Wolters Kluwer Health Inc Web site. Available at: http://online.factsandcomparisons.com/ MonoDisp.aspx?book=DFC&monoID=fandchcp11537&searched=Omeprazole. Accessed December 7, 2006.
27. Omeprazole. Drugdex® System [intranet]. Version 5.1. Greenwood Village, Colo: Thomson Micromedex. Available at: http://www.thomsonhc.com. Accessed December 7, 2006.
28. Cimetidine. Drugdex® System [intranet]. Version 5.1. Greenwood Village, Colo: Thomson Micromedex. Available at: http://www.thomsonhc.com. Accessed December 7, 2006.
29. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patient: resolving discordant meta analyses. JAMA. 1996;275:308-314.
30. Lam NP, Le PD, Crawford SY, et al. National survey of stress ulcer prophylaxis. Crit Care Med. 1999;27:98-103.
31. Cook DJ, Witt LG, Cook RJ, et al. Stress ulcer prophylaxis in the critically ill: a meta-analysis. Am J Med. 1991;91:519-527.
32. Welage LS. Overview of pharmacologic agents for acid suppression in critically ill patients. Am J Health Syst Pharm. 2005;62(10, suppl 2):S4-S10.
33. Spirt MJ. Stress-related mucosal disease. Curr Treat Options Gastroenterol. 2003;6(2):135-145.
34. Carafate [package insert]. Birmingham, Ala: Axcan Scandipharm; 2004.
35. Garcia-Luna PP, Garcia E, Pereira JL, et al. Esophageal obstruction by solidification of the enteral feed: a complication to be prevented. Int Care Med. 1997;23:790-792.
36. Prod'hom G, Leuenberger P, Koerfer J, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. Ann Intern Med. 1994;120:6553-6662.
37. Safdar N, Crnich C, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care. 2005;50:725-739.
38. Tryba M. The gastropulmonary route of infection - fact or fiction? Am J Med. 1991;91(suppl 2A):135S-146S.
39. Apte NM, Karnad DR, Medhekar TP, et al. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial. Crit Care Med. 1992;20:590-593.
40. Martin LF, Booth FVM, Karlstadt RG, et al. Continuous intravenous cimetidine decreases stress-related gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med. 1993;21:19-30.
41. Devlin JW. Treatment options and formulary considerations in the management of acid suppression in critically ill patients. Am J Health Syst Pharm. 2005;62(10, suppl 2):S2-S3.
42. 2 antagonist-induced thrombocytopenia: is this a real phenomenon? Intensive Care Med. 2002;28:459-465.
43. Lasky MR, Metzler MH, Phillips JO. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J Trauma. 1998;44:527-533.
44. Conrad SA, Gabrielli A, Margolis B, et al. Randomized, double-blind comparison of immediate-release omeprazole suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med. 2005;33:760-765.
45. Jung R, MacLaren R. Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients. Ann Pharmacother. 2002;36:1929-1937.
46. Ziegler AB. The role of proton pump inhibitors in acute stress ulcer prophylaxis in mechanically ventilated patients. Dimens Crit Care Nurs. 2005;24:109-114.
47. Dial S, Alrasadi K, Manoukian C, et al. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ. 2004;171:33-38.
48. Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care. 2005;20:35-45.
49. Levy MJ, Seelig CB, Robinson NJ, et al. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci. 1997;42:1255-1259.
50. Phillips JO, Metzler MH, Palmieri MT, et al. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med. 1996;24:1793-1800.